Healthcare leaders are developing AI governance frameworks to balance innovation with patient safety, security, and regulatory compliance.
Owkin and AstraZeneca are expanding their AI collaboration to develop new drug discovery models using federated learning, a technique that…
The 2026 MIT Technology Review list highlights a first-in-human personalized gene editing trial that will reshape pharmaceutical workflows and force…
Modern AI tools can reidentify patients by cross matching data fragments, requiring healthcare staff to learn new deidentification and prompt…
Pennsylvania regulators argue that AI chatbots mimicking psychiatrists and other doctors violate state medical licensing laws and pose direct risks…
AIMed 2026 brought together leading clinicians, researchers, and regulators in Kraków to tackle the central challenge of modern healthcare AI…
More than 650 medical professionals gathered at Cleveland Clinic’s inaugural AI Summit.
A neural network model accurately classifies brain tumors using non-invasive genetic data, enabling faster and safer cancer diagnosis.